Gender differences in the relationship between symptoms of depression and high-sensitivity CRP

International Journal of Obesity

Volumn 37, Issue , 2013, Pages S38-S43

  Vetter, M L ^a,b   Wadden, T A ^b,c   Vinnard, C ^d   Moore, R H ^b,e   Khan, Z ^b   Volger, S ^b   Sarwer, D B ^b   Faulconbridge, L F ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HAVERFORD COLLEGE   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Depression; Gender; High sensitivity C reactive protein; Overweight

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SEX DIFFERENCE; WEIGHT REDUCTION;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DEPRESSION; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OBESITY; PENNSYLVANIA; PRIMARY HEALTH CARE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEX FACTORS;

EID: 84882305661     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2013.95     Document Type: Article

References (41)

1. Anda R, Williamson D, Jones D, Macéra C, Eaker E, Glassman A et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 1993; 4: 285-294.
2. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996; 93: 1976-1980.
3. Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML. Depression as an antecedent to heart disease among women and men in NHANES I study. National Health and Nutrition Examination Survey. Arch Intern Med 2000; 160: 1261-1268.
4. Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: systematic review and metaanalysis. Int J Geriatr Psychiatry 2007; 22: 613-626.
5. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and pathogenesis of depression. Trends Immunol 2006; 27: 24-31.
6. Miller AH. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun 2009; 23: 149-158.
7. Dowlati Y, Herrman N, Swardfager W, Liu H, Sham L, Reim EK et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446-457.
8. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-2135.
9. Nguyen XM, Lane J, Smith BR, Nguyen NT. Changes in inflammatory biomarkers across weight classes in a representative US population: link between obesity and inflammation. J Gastrointest Surg 2009; 13: 1205-1212.
10. Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-a, and IL-6. Diabetes Res Clin Pract 2005; 69: 29-35.
11. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979.
12. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97: 425-428.
13. Koenig W, Sund M, Fröhlich M, Fischer HG, Löwel H, Döring A et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237-242.
14. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vase Biol 1997; 17: 1121-1127.
15. Kuller LH, Tracy RP, Shaten J, Meilahn EN. for the MRFIT Research Group. Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996; 144: 537-547.
16. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997; 349: 462-466.
17. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999; 45: 2136-2141.
18. Pearson TA, Mensah GA, Alexander RW. Centers for Disease Control and Prevention, American Heart Association Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement of healthcare professions from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
19. Danner M, Kasl SV, Abramson JL, Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom Med 2003; 65: 347-356.
20. Ford DE, Erlinger TP. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2004; 164: 1010-1014.
21. Pennix BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S et al. Inflammatory markers and depressed mood in older persons: reasons from the Health, Aging, and Body Composition study. Biol Psychiatry 2003; 54: 566-572.
22. Howren MB, Lamkin DM, Suis J. Association of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009; 71: 171-186.
23. Elovainio M, Aalto AM, Kivimäki M, Pirkola S, Sundvall J, Lönnqvist J et al. Depression and C-reactive protein: population-based Health 2000 study. Psychosom Med 2009; 71: 423-430.
24. Bremmer MA, Beekman AT, Deeg DJ, Pennix BW, Dik MG, Hack CE et al. Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 2008; 106: 249-255.
25. Hemingway H, Marmot M. Psychosocial factors in the etiology and prognosis of coronary heart disease: systematic review of prospective cohort studies. BMJ 1999; 318: 1460-1467.
26. Janszky I, Lekander M, Blom M, Georgiades A, Ahnve S. Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease. Brain Behav Immun 2005; 19: 555-563.
27. Ladwig KH, Marten-Mittag B, Lowel H, Doring A, Koenig W. Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men. Brain Behav Immun 2003; 17: 268-275.
28. Whooley MA, Caska CM, Hendrickson BE, Rourke MA, Ho J, Ali S. Depression and inflammation in patients with coronary artery disease: findings from the Heart and Soul study. Biol Psychiatry 2007; 62: 314-320.
29. Wadden TA, Volger S, Sarwer DB, Vetter ML, Tsai AG, Berkowitz RI et al. A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med 2011; 365: 1969-1979.
30. Expert Panel on Detection and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on the detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
31. Martin RF. General Deming regression for estimating systematic bias and its confidence interval in method comparison studies. Clin Chem 2000; 46: 100-104.
32. Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord 2009; 114: 163-173.
33. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edn. American Psychiatric Association: Washington, DC, USA, 1994.
34. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613.
35. World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. World Health Organ Tech Rep Ser 1995; 854: 1-452.
36. Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008; 60: 10-18.
37. Ma Y, Chiriboga DE, Pagoto SL, Rosal MC, Li W, Merriam PA et al. Association between depression and C-reactive protein. Cardiol Res Pract 2011; e-pub ahead of print 22 December 2010; doi:10.4061/2011/286509.
38. Evans EM, Van Pelt RE, Binder EF, Williams DB, Ehsani AA, Kohrt WM. Effects of HRT and exercise training on insulin action, glucose tolerance, and body composition of older women. J Appl Physiol 2001; 90: 2033-2040.
39. Haider I, Marsland AL, Cheong J, Muldoon MF, Ferrell RE, Manuck SB. Polymorphisms in the CRP gene moderate an association between depressive symptoms and circulating levels of C-reactive protein. Brain Behav Immun 2010; 24: 160-167.
40. Douglas KM, Taylor AJ, O'Malley PG. Association between depression and C-reactive protein in a screening population. Psychosom Med 2004; 66: 679-683.
41. Dixon JB, Hayden MJ, Lambert GW, Dawood T, Anderson ML, Dixon ME., ML, ME et al. Raised CRP levels in obese patients: symptoms of depression have an independent positive association. Obesity 2008; 16: 2010-2015.